PM-M05_04: Monitoring the comorbidities Comorbidity Register NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status RCA for low performance of Percentage of TB Notified Patients with known HIV Status Reporting of ICF activities among PLHIV Monitoring of indicators related to TB-HIV Monitoring of indicators related to TB-HIV Treatment Monitoring of indicators related to TB-HIV prevention TB-HIV joint review mechanisms Performance Indicators and Targets for TB-HIV Collaborative Activities Quarterly report on TB-HIV Collaborative Activities Ni-kshay HIV Status Report
PM-M04_05: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment Shorter oral Bedaquiline-containing MDR/RR-TB regimen Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Replacement Sequence of Drugs Follow up sputum examination for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
PM-M04_06: Longer Oral M/XDR-TB Regimen Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen Eligibility Criteria for Longer Oral M/XDR-TB Regimen Longer Oral M/XDR-TB: Regimen and Duration Treatment Extension in Longer Oral M/XDR-TB Regimen Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen Follow up sputum examination for Longer Oral M/XDR-TB DR-TB Regimen
PM-M04_04: Isoniazid [H] Mono/Poly DR-TB Regimen Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation Eligibility Criteria for H Mono/poly DR-TB Regimen Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen Replacement Sequence in the H Mono/Poly DR-TB Follow up sputum examination for Isoniazid [H] Mono/Poly DR-TB Regimen